Claim Missing Document
Check
Articles

Found 2 Documents
Search

Frequency Of Cyp3a5 (A6986g) Gene Polymorphism In Patients With BA, COPD, And ACO Raufov A.A.,; FayzullaevaN.Ya.; Ruzibakieva M.R.
Procedia of Social Sciences and Humanities Vol. 2 (2022): Proceedings of the 1st International Conference on Community Education, Economics, Ps
Publisher : Universitas Muhammadiyah Sidoarjo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21070/pssh.v2i.109

Abstract

Asthma and COPD are the most common chronic respiratory diseases, each with a specific pathophysiology. Usually, asthma is characterized by chronic inflammation of the airways with reversible symptoms, while COPD is characterized by persistent respiratory changes in the bronchopulmonary system. However, patients can sometimes have clinical features of both diseases, and this condition is called the asthma-COPD overlap (ACO) recommended by the joint guidelines of GINA (Global Strategy for the Management and Prevention of Asthma) and GOLD (Global Initiative on Chronic Obstructive Pulmonary Disease). According to this guide, ACOis characterized by "permanent airflow limitation with some features of asthma and COPD."
Frequency Of Cyp3a5 (A6986g) Gene Polymorphism In Patients With BA, COPD, And ACO Raufov A.A.,; FayzullaevaN.Ya.; Ruzibakieva M.R.
Procedia of Social Sciences and Humanities Vol. 2 (2022): Proceedings of the 1st International Conference on Community Education, Economics, Ps
Publisher : Universitas Muhammadiyah Sidoarjo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21070/pssh.v2i.109

Abstract

Asthma and COPD are the most common chronic respiratory diseases, each with a specific pathophysiology. Usually, asthma is characterized by chronic inflammation of the airways with reversible symptoms, while COPD is characterized by persistent respiratory changes in the bronchopulmonary system. However, patients can sometimes have clinical features of both diseases, and this condition is called the asthma-COPD overlap (ACO) recommended by the joint guidelines of GINA (Global Strategy for the Management and Prevention of Asthma) and GOLD (Global Initiative on Chronic Obstructive Pulmonary Disease). According to this guide, ACOis characterized by "permanent airflow limitation with some features of asthma and COPD."